Clinical Trial Update: Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates a treosulfan/fludarabine/low-dose total body irradiation preparative regimen for children with acute myeloid leukemia or myelodyspl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Fludarabine (Fludarabine)
• Low-dose total body irradiation (total body irradiation)
• Treosulfan (treosulfan)

Snippet

Sponsor: Center for International Blood and Marrow Transplant Research | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | Status: COMPLETED